[1]
Gulliver, W., Sussman, G., Hebert, J., Lynde, C.W., Papp, K.A., Yang, W.H., Chambenoit, O., Viera, A., DeTakaosy, F. and Rihakova, L. 2018. Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S52. DOI:https://doi.org/10.25251/skin.2.supp.52.